Recommended Conferences

Cancer-Treatment and Therapeutics

New York, USA
Related Subjects
 

Sézary cell counts in erythrodermic cutaneous T-cell lymphoma: implications for prognosis and staging

Author(s): Vonderheid EC, Pena J, Nowell P

Abstract

In this retrospective study, quantitative Sézary cell counts were performed at presentation on 192 patients with erythrodermic cutaneous T-cell lymphoma (E-CTCL). Per recommendation of the International Society of Cutaneous Lymphomas (ISCL), the impact on staging of using an absolute Sézary cell count of 1.0 K μL−1 or more as equivalent to lymph node involvement was investigated. Of 132 patients with disease initially classified at stage III using the current TNM staging system, 25% were up staged to IVa, resulting in a clearer separation of associated survival curves between the stages. Furthermore, the current ISCL definition of B0, B1 and B2 ratings were improved using Sézary cell count levels of < 1.0 K μL−1, ≥ 1.0 – 4.99 K μL−1 and ≥ 5.0 K μL−1, respectively. These modified B ratings potentially could be used in an alternative staging system for E-CTCL without N rating. Advanced age, prior exposure to multiple systemic drugs, enlargement of peripheral lymph nodes (>3 cm), other measures of blood tumor burden (CD4/CD8 ratio ≥ 10, chromosomally-abnormal clone) and 2-fold increase in serum LDH level were other factors of prognostic significance. The clinical importance of these variables vis-à-vis the modified TNBM staging system will need to be clarified in future studies.

Similar Articles

Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma

Author(s): Scarisbrick JJ, Whittaker S, Evans AV, Fraser-Andrews EA, Child FJ, et al.

Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with Sézary syndrome

Author(s): Fraser-Andrews EA, Russell-Jones R, Woolford AJ, Wolstencroft RA, Dean AJ, et al.

Usefulness of KIR3DL2 to Diagnose, Follow-Up, and Manage the Treatment of Patients with Sézary Syndrome

Author(s): Hurabielle C, Thonnart N, Ram-Wolff C, Sicard H, Bensussan A, et al.

T cell clonality assessment: past, present and future

Author(s): Mahe E, Pugh T, Kamel-Reid S